Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.
Clinical trial NCT02588833 · COMPLETED
Trial details
- NCT number
- NCT02588833
- Sponsor
- Apellis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2019-08-26
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.